Viewing StudyNCT05762510



Ignite Creation Date: 2024-05-06 @ 6:44 PM
Last Modification Date: 2024-10-26 @ 2:53 PM
Study NCT ID: NCT05762510
Status: RECRUITING
Last Update Posted: 2023-05-09
First Post: 2022-01-06

Brief Title: A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia TDT
Sponsor: First Affiliated Hospital of Guangxi Medical University
Organization: First Affiliated Hospital of Guangxi Medical University

Conditions & Keywords Data

Conditions:
Name
Transfusion Dependent Beta-Thalassemia
Keywords:
Name View
CD34 View
LentiRed View
Beta-Thalassemia View
Human Hematopoietic Stem Cell View
gene therapy View